Brief: Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 Million
26/08/2026 06:08
BRIEF-Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 Million Aug 26 (Reuters) - Island Pharmaceuticals Ltd ILA.AX:
NO DIVIDENDS PAID, RECOMMENDED OR DECLARED DURING CURRENT FINANCIAL PERIOD
FY PRELIM INCOME FROM ORDINARY ACTIVITIES UP 214.6% TO A$559,080
PRELIM FY LOSS ATTRIBUTABLE OF A$9.8 MILLION
Further company coverage: ILA.AX
((reuters.briefs@thomsonreuters.com))
Recent news on Island Pharmaceuticals
See all newsBrief: Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA Pathway
Brief: Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 Million
Australia's Island Pharmaceuticals rises as company boosts Galidesivir production
Brief: Island Pharmaceuticals Boosts Galidesivir Supply As Ebola Surges
Island Pharmaceuticals hits seven-month high on Galidesivir approval for Ebola epidemic